Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference
Management will also be available during the event for one-on-one meetings with the investment community. To schedule a meeting, please contact your NobleCon representative or KCSA Strategic Communications by emailing INBS@kcsa.com.NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will present at the upcoming Noble Capital Markets' 20th Annual Emerging Growth Equity Conference on December 3-4, 2024, in Boca Raton, FL.
纽约，2024年11月21日（环球新闻社）--智能生物解决方案公司（纳斯达克：INBS）（"INBS"或"公司"），一家提供智能、快速、无创检测解决方案的医疗科技公司，今天宣布其管理团队将于2024年12月3-4日在弗罗里达博卡拉顿举行的诺贝尔资本市场第20届新兴增长股权会议上发表演讲。
Noble Capital Markets' 20th Annual Emerging Growth Equity Conference
Dates: December 3-4, 2024
Location: Florida Atlantic University, Boca Raton, FL
Presentation Day and Time: Wednesday, December 4, 2024, at 2:00 p.m. ET
Presentation Location: Presentation Room 3
诺贝尔资本市场第20届新兴增长股权会议
日期：2024年12月3-4日
地点：佛罗里达大西洋大学，博卡拉顿，FL
演讲日期和时间：2024年12月4日，美国东部时间下午2:00
演讲地点：演讲厅3
A link to the recording of the presentation will be available on INBS's Investor Relations website two days after the event.
INBS投资者关系网站上将在活动结束后两天提供演示录像的链接。
Management will also be available during the event for one-on-one meetings with the investment community. To schedule a meeting, please contact your NobleCon representative or KCSA Strategic Communications by emailing INBS@kcsa.com.
管理层还将在活动期间与投资社区进行一对一会议。要安排会议，请通过电子邮件联系您的NobleCon代表或KCSA战略通信的INBS代表。
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company's current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.
关于智能生物解决方案股份有限公司：智能生物解决方案股份有限公司（纳斯达克：INBS）是一家提供创新、快速、无创检测解决方案的医疗技术公司。该公司认为其智能指纹毒品筛查系统将通过指纹汗液分析，革新便携式测试，具有更广泛的应用前景。作为一种卫生和经济高效的系统，该测试可对在职场常见的药物使用（包括阿片类、可卡因、甲基苯丙胺和大麻）进行筛查。该技术在数秒内完成采样并在不到十分钟内得出结果，对于安全关键行业的雇主来说，这将是一种宝贵的工具。另外，该公司的生物传感器平台有潜力检测各种疾病症状，包括传染病到免疫性疾病。该公司目前的客户群包括建筑、制造和工程、运输和物流公司、药物治疗机构和验尸官。
纳斯达克：Intelligent Bio Solutions Inc. (INBS)是一家医疗技术公司，提供创新、快速、非侵入性的测试解决方案。该公司认为其Intelligent Fingerprinting毒品筛查系统将通过指纹汗液分析革新便携式测试，这具有在其他领域中有更广泛应用潜力。设计为卫生和经济实惠的系统，该测试旨在筛查最近在工作场所常见的药物使用，包括阿片类药物、可卡因、冰毒和大麻。采样只需几秒钟，结果在不到十分钟内出来，这项技术将成为安全关键行业雇主的宝贵工具。该公司目前在美国以外的客户群包括建筑、制造和工程、运输和物流公司、药物治疗机构和法医。
For more information, visit:
请访问：
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
公司联系方式：
智能生物解决方案公司
info@ibs.inc
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
投资者及媒体联系方式：
Valter Pinto，董事总经理
KCSA战略传播
PH：(212) 896-1254
INBS@kcsa.com
